Elaboration of Pharmacopoeial Quality Standards for Bacteriophage Products

Bacteriophages are novel safe and efficacious medicinal products that are used for treatment of intestinal infections and purulent inflammations. The fact that virulent phages can be adapted to fight antibiotic-resistant bacterial strains makes this group of medicines a promising means of treatment of infections associated with medical interventions. The elaboration of quality standards for bacteriophage products will enable alignment of the quality requirements and test methods. There are no monographs on bacteriophage products in pharmacopoeias of other countries, therefore, the development of general chapters on groups of test methods used in bacteriophage quality control and monographs on bacteriophages for the State Pharmacopoeia of the Russian Federation (Ph. Rus.) was a very relevant and timely initiative. The aim of the study was to elaborate pharmacopoeial quality standards for bacteriophages approved in the Russian Federation for therapeutic and prophylactic indications. The authors of the study analysed product specification files and master production records for bacteriophages produced in the Russian Federation. They determined common GMP-compliant production steps, the selection criteria for bacteriophage strains and bacteria production strains, and cultivation and storage conditions. The authors standardised bacteriophage quality parameters and brought the test methods in line with the test procedures described in the Ph. Rus., 14th ed. The study summarised test methods used for identification of bacteriophages and determination of their specific activity. The main results of the study were included into the general monograph «Bacteriophages» and individual monographs on bacteriophage products that were included into the current edition of the Ph. Rus. Further studies and elaboration of new quality standards for mono- and multicomponent bacteriophage products, and the use of such products in clinical practice will improve prophylaxis and treatment of various infectious diseases.

bacteriophages, medicinal products, general chapter, general monograph, monograph, test methods, quality parameters

1. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–22. https://doi.org/10.1126/science.284.5418.1318

2. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003;2:114–22. https://doi.org/10.1038/nrd1008

3. Chambless JD, Hunt SM, Stewart PS. A three-dimensional computer model of four hypothetical mechanisms protecting biofilms from antimicrobials. Appl Environ Microbiol. 2006;72(3):2005–13. https://doi.org/10.1128/AEM.72.3.2005-2013.2006

4. Tetz VV. The effect of antimicrobial agents and mutagen on bacterial cells in colonies. Med Microbiol Lett. 1996;(5):426–36.

5. Tetz VV, Korobov VP, Artemenko NK, Lemkina LM, Panjkova NV, Tetz GV. Extracellular phospholipids of isolated bacterial communities. Biofilms. 2004;1(3):149–55. http://dx.doi.org/10.1017/S147905050400136X

6. Sponza DT. Investigation of extracellular polymer substances (EPS) and physicochemical properties of different activated sludge flocs under steady-state conditions. Enzyme Microb Technol. 2003;32(3–4):375–85. https://doi.org/10.1016/S0141-0229(02)00309-5

7. Akimkin VG, Darbeeva OS, Kolkov VF. Historical and modern aspects of bacteriophages application: experience and prospects. Klinicheskaya praktika = Journal of Clinical Practice. 2010;(4):48–54 (In Russ.)

8. Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981–1986. Arch Immunol Ther Exp. 1987;35(5):569–83.

9. Tsulukidze AP. The technique application of bacteriophage in surgical practice. Vestnik khirurgii =Bulletin of Surgery. 1941;(6):679–85 (In Russ.)

10. Kokin GA. The use of phages in surgery. Sovetskaya meditsina = Soviet Medicine. 1941;(9):15–8 (In Russ.)

11. Zhuravlev PM, Kokin GA, Pokrovskaya MP. Phagotherapy and phagoprophylaxis of gas gangrene. Zhurnal mikrobiologii, epidemiologii i immunobiologii = Journal of microbiology epidemiology and immunobiology. 1944;(9):44 (In Russ.)

12. Avksentyeva VA, Altyrtseva IE, Burukina AV, Zobnina KS, Gelshan LS, Kuznetsova GS, Minkevich EI. To the question of increasing the therapeutic effectiveness of dysentery bacteriophage. Bacteriophagy. Proceedings of the inter-institute conference. Tbilisi. 1957;115–21 (In Russ.)

13. Rappe FI, Zobnina KS, Kuznetsova VK, Davydova KP, Dunaeva NN. Development of methods for obtaining highly active dysenteric bacteriophage taking into account the microbial landscape in the focus of infection. Bacteriophagy. Proceedings of the inter-institute conference. Tbilisi. 1957;159–61 (In Russ.)

14. Kislyak NS, Samsygina GA, Boni EG. Staphylococcal bacteriophage in the treatment of purulent-inflammatory diseases of newborns. In: Materials of the All-Union symposium on the 60th anniversary of the Tbilisi NIIIVS. Tbilisi; 1984. P. 212–4 (In Russ.)

15. Bessmertnaya NG, Chizhova GV, Vladimirova NYu, Kogut EP. Effectiveness of the use of pyobacteriophage in pregnant women with pyelonephritis. In: Plenum of the Russian Association of Obstetricians and Gynecologists «Infections in obstetrics, gynecology and perinatology». Collection of scientific papers. Saratov; 1999. P. 35–6 (In Russ.)

16. Lakhno VM, Khomyakova EYu, Kuznetsov YuV. The use of phage therapy for the treatment of infectious complications after appendectomy. Vesti meditsiny = Medicine News. 1996;(5–6):5 (In Russ.)

17. Seryezhin IN, Dautova ZA, Nikova GA, Fattakhov VT. The first results of the use of piobacteriophage polyvalent in the prevention of wound infection of the eye. In: Materials of the scientific-practical conference «Vital problems of ophthalmology». Ufa; 1996. P. 24 (In Russ.)

18. Meladze GD, Mebuke MG, Chkhetia NSh, Kiknadze NYa. Effectiveness of staphylococcal bacteriophage in the treatment of gneumable lung and pleura diseases. The efficacy of staphylococcal bacteriophage in the treatment of purulent diseases of the lungs and pleura Grudnaya khirurgiya. 1982;(1):53–6 (In Russ.)

19. Lazareva EB, Spiridonova TG, Bitkova EE, Lashenkova NN, Kudryavtseva NI, Men’shikov DD. The effectiveness of oral use of bacteriophages for the treatment of patients with burns. In: Opportunities and prospects for improving diagnosis and treatment in clinical practice: Abstracts of the scientific-practical conference, November 13, 1997. Moscow; 1997. P. 41–2 (In Russ.)

20. Kochetkova VA, Mamontov AS, Moskovtseva RL, Erastova EI, Trofimov EI, Popov MI, Dzhubalieva SK. Phage therapy of postoperative purulent-inflammatory complications in cancer patients. Sovetskaya meditsina = Soviet Medicine. 1989;(6):23–6 (In Russ.)

21. Perepanova TS, Malova YuA, Tolordava ER, Kruglov AN. Prevention and treatment with drugs of bacteriophage urinary tract infections. In: Bacteriophages: theoretical and practical aspects of their application in medicine, veterinary and food: book of abstracts of the fourth international scientific conference: to the 70th anniversary of professor V.A. Aleshkin, Nizhni Novgorod, September 24–26. Moscow: Meditsinskoe Marketingovoe Agentstvo; 2018. Р. 56 (In Russ.)

22. Akimkin VG. Elimination of the chronic epidemic of nosocomial salmonellosis in a large multidisciplinary treatment facility using adapted salmonella bacteriophage. In: Actual issues of the epidemiology of infectious diseases: a collection of scientific papers. Moscow; 1997. P. 206–9 (In Russ.)

23. Guttman B, Raya R, Kutter E. General biology of bacteriophages. In: Kutter E, Sulakvelidze A, eds. Bacteriophages: biology and practical application. Moscow: Nauchnyy mir; 2012. P. 58–110 (In Russ.)

24. Krasilnikov IV, Lysko KA, Otrashevskaya EV, Lobastova AK. Bacteriophage based preparations: a brief survey of current state and future development. Sibirskiy meditsinskiy zhurnal = Siberian Medical Journal. 2011;26(2):33–7 (In Russ.)

25. Bacteriophage: Genetics and Molecular Biology. Mc Grath S, van Sinderen D, eds. Norfolk. UK: Caister Academic Press, 2007.

26. Kargina TM, Osipova IG, Sakanyan EI, Movsesyants AA. The history of development of Pharmacopoeia standards quality biological drugs and methods of tests in Russia. BIOpreparaty. Profilaktika, diagnostika, lecheniye = BIOpreparations. Prevention, Diagnosis, Treatment. 2016;16(3):131–8 (In Russ.)

27. Orlova EV, Efimova MG, Funkner EV, Nikolaeva AM, Kovyazina NA, Shitova OI, Shilova EG. Technological aspects of the development of bacteriophage preparations and the effectiveness of their use. In: Bacteriophages: theoretical and practical aspects of their application in medicine, veterinary and food: book of abstracts of the fourth international scientific conference: to the 70th anniversary of professor V.A. Aleshkin, Nizhni Novgorod, September 24–26. Moscow: Meditsinskoe Marketingovoe Agentstvo; 2018. P. 55 (In Russ.)

28. Sakanyan EI, Shemeryankina TB, Osipova IG, Kargina TM, Shishova LI, Barmin AB, et al. Creation of pharmacopeia quality standards for the State Pharmacopeia of the Russian Federation. Khimiko-farmatsevticheskii zhurnal = Pharmaceutical Chemistry Journal. 2017;51(2):40–5 (In Russ.) https://doi.org/10.30906/0023-1134-2017-51-2-40-45

29. Mironov AN, Movsesyants AA, Bondarev VP, Ozeretskovsky NA, Shimchuk LF. Highlights of elaborating pharmacopeia monographs for immunobiological preparations. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya = The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2013;(2):57–9 (In Russ.)

30. Movsesyants AA, Bondarev VP, Olefir YV, Merkulov VA, Shimchuk LF. Quality standards for immunobiological medicinal products – new texts in the State Pharmacopoeia of the Russian Federation. Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo primeneniya = The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2016;(2):38–41 (In Russ.)